Adam R. Craig
2019
In 2019, Adam R. Craig earned a total compensation of $1.7M as President, Chief Executive Officer and Interim Chief Medical Officer at CTI BioPharma, a 44% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $396,000 |
|---|---|
| Option Awards | $702,520 |
| Salary | $595,447 |
| Other | $8,400 |
| Total | $1,702,367 |
Craig received $702.5K in option awards, accounting for 41% of the total pay in 2019.
Craig also received $396K in non-equity incentive plan, $595.4K in salary and $8.4K in other compensation.
Rankings
In 2019, Adam R. Craig's compensation ranked 6,702nd out of 13,971 executives tracked by ExecPay. In other words, Craig earned more than 52.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,702 out of 13,971 | 52nd |
Division Manufacturing | 2,554 out of 5,701 | 55th |
Major group Chemicals And Allied Products | 933 out of 2,200 | 58th |
Industry group Drugs | 788 out of 1,886 | 58th |
Industry Pharmaceutical Preparations | 576 out of 1,398 | 59th |
Source: SEC filing on April 23, 2020.
Craig's colleagues
We found two more compensation records of executives who worked with Adam R. Craig at CTI BioPharma in 2019.